Indoco Remedies transfers ophthalmic division to Sunways India

Indoco Remedies Ltd. announced the strategic transfer of its ophthalmic business in India and agreed territories in Africa to Sunways (India) Private Limited. The Board approved this divestment, which Indoco Remedies states will allow it to sharpen its focus on core therapeutic areas with stronger potential. For Sunways, the transaction is expected to strengthen its ophthalmology platform by adding an established operating business and complementing its existing product portfolio and manufacturing capabilities. Sunways is a specialized pharmaceutical company focusing on ophthalmology and ENT formulations. Both companies' management highlighted the strategic benefits of the transaction for their respective businesses.